Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update

Dunlay, Shannon M., Givertz, Michael M., Aguilar, David, Allen, Larry A., Chan, Michael, Desai, Akshay S., Deswal, Anita, Dickson, Victoria Vaughan +6 more·2019·Circulation

DOI 10.1161/cir.0000000000000691

Cited by (649)

Items 101–200 of 649

Tirzepatide: A novel cardiovascular protective agent in type 2 diabetes mellitus and obesity
Muhammad Bilal Sardar, Zain Ali Nadeem, Muhammad Babar · 2024 · Current Problems in Cardiology
Strategies of Unloading the Failing Heart from Metabolic Stress
Efstratios Koutroumpakis, Bartosz Jozwik, David A. Aguilar, Heinrich Taegtmeyer · 2019 · The American Journal of Medicine
Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial
Jawad H. Butt, Pardeep S. Jhund, Alasdair David Henderson, Brian Lee Claggett, Akshay Suvas Desai, Prabhakar Viswanathan, Peter Kolkhof, Patrick Schloemer, Flaviana Amarante, Carolyn S.P. Lam et al. · 2025 · The Lancet Diabetes & Endocrinology
Impact of sodium–glucose transport protein-2 (SGLT2) inhibitors on the inflammasome pathway in acute myocardial infarction in type 2 diabetes mellitus: a comprehensive review
Thomas T. Yoo, In Hae Baek, Liset N. Stoletniy, Anthony A. Hilliard, Antoine Emile Sakr, Desislava Met Doycheva · 2025 · Cardiovascular Diabetology
Lipid in the midst of metabolic remodeling – Therapeutic implications for the failing heart
Tiến Dũng Nguyễn, Paul Christian Schulze · 2020 · Advanced Drug Delivery Reviews
Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic Cardiomyopathy
Amit K. Rai, Brooke Lee, Ramesh Gomez, Deepu Rajendran, Mahmood Khan, Venkata Naga Srikanth Garikipati · 2021 · Frontiers in Physiology
Potential molecular mechanism underlying cardiac fibrosis in diabetes mellitus: a narrative review
Muhammad Qomaruddin Ridwan, Herlina Dimiati, Maimun Syukri, Ronny Lesmana · 2023 · The Egyptian Heart Journal
Preventing new-onset heart failure: Intervening at stage A
Bharathi Upadhya, Shriram Hegde, Manasi Tannu, Richard Brandon Stacey, Andreas P. Kalogeropoulos, Douglas D. Schocken · 2023 · American Journal of Preventive Cardiology
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions
Alfredo Caturano, Erica Vetrano, Raffaele Galiero, Celestino Sardu, Luca Rinaldi, Vincenzo Russo, Marcellino Monda, Raffaele Marfella, Ferdinando Carlo Sasso · 2024 · International Journal of Molecular Sciences
Gut microbiota-derived imidazole propionate: an emerging target for the prevention and treatment of cardiometabolic diseases
Yan Zeng, Qi Wu, Man Guo, Fang‐Yuan Teng, C Jiang, Jiao Chen, Xiaozhen Tan, Chen Zeng, Yang Long, Betty Yuen Kwan Law et al. · 2025 · Frontiers in Endocrinology
Impact of diabetes mellitus on the outcomes of subjects with hypertrophic cardiomyopathy: A nationwide cohort study
Hyun‐Jung Lee, Hyung‐Kwan Kim, Bong‐Seong Kim, Kyung-Do Han, Tae‐Min Rhee, Jun‐Bean Park, Heesun Lee, Seung‐Pyo Lee, Yong-Jin Kim · 2022 · Diabetes Research and Clinical Practice
Cost-Utility Analysis of Combination Empagliflozin and Standard Treatment Versus Standard Treatment Alone in Thai Heart Failure Patients with Reduced or Preserved Ejection Fraction
Rungroj Krittayaphong, Unchalee Permsuwan · 2022 · American Journal of Cardiovascular Drugs
The Role of Echocardiography in Evaluating Cardiovascular Diseases in Patients with Diabetes Mellitus
Sun Hwa Lee, Jae‐Hyeong Park · 2023 · Diabetes & Metabolism Journal
The Combination Effect of Aspalathin and Phenylpyruvic Acid-2-O-β-d-glucoside from Rooibos against Hyperglycemia-Induced Cardiac Damage: An In Vitro Study
Phiwayinkosi Vusi Dludla, Christo J. F. Muller, Johan Louw, Sithandiwe Eunice Mazibuko-Mbeje, Luca Tiano, Sonia Silvestri, Patrick Orlando, Fabio Marcheggiani, Ilenia Cirilli, Nireshni Chellan et al. · 2020 · Nutrients
Heart failure and diabetes: role of ATM
Mary C. Wingard, Chad R. Frasier, Mahipal Singh, Krishna Singh · 2020 · Current Opinion in Pharmacology
Loss of Lipocalin 10 Exacerbates Diabetes-Induced Cardiomyopathy via Disruption of Nr4a1-Mediated Anti-Inflammatory Response in Macrophages
Qianqian Li, Yutian Li, Wei Chieh Huang, Xiaohong Wang, Zhenling Liu, Jing Chen, Yanbo Fan, Tianqing Peng, Sakthivel Sadayappan, Yigang Wang et al. · 2022 · Frontiers in Immunology
Interconnected Clinical and Social Risk Factors in Breast Cancer and Heart Failure
Arjun Sinha, Avni A. Bavishi, Elizabeth A. Hibler, Eric H. Yang, Susmita Parashar, Tochukwu M. Okwuosa, Jeanne M. DeCara, Sherry-Ann N. Brown, Avirup Guha, Diego B. Sadler et al. · 2022 · Frontiers in Cardiovascular Medicine
Empagliflozin ameliorates diabetic cardiomyopathy via regulated branched-chain amino acid metabolism and mTOR/p-ULK1 signaling pathway-mediated autophagy
Lin Zhang, Heming Zhang, Xiuzhu Xie, Ruping Tie, Xiaolin Shang, Qianqian Zhao, Junjie Xu, Liyuan Jin, Jinying Zhang, Ping Ye · 2023 · Diabetology & Metabolic Syndrome
Heart failure in patients with type 2 diabetes mellitus: assessment with echocardiography and effects of antihyperglycemic treatments
Katsuomi Iwakura · 2019 · Journal of Echocardiography
The Continuum of Prevention and Heart Failure in Cardiovascular Medicine: A Joint Scientific Statement from the Heart Failure Society of America and The American Society for Preventive Cardiology
Anuradha Lala, Craig James Beavers, Vanessa L. Blumer, LaPrincess C. Brewer, Diana De Oliveira-Gomes, Sandra Barker Dunbar, Hannah Every, Richard Ferraro, Bonnie Ky, James L. Januzzi et al. · 2025 · Journal of Cardiac Failure
Towards clinical application of GlycA and GlycB for early detection of inflammation associated with (pre)diabetes and cardiovascular disease: recent evidence and updates
Erik Fung, Eunice Y. S. Chan, Kwan Hung Ng, Ka Man Yu, Huijun Li, Yulan Wang · 2023 · Journal of Inflammation
Gaussian process-based kernel as a diagnostic model for prediction of type 2 diabetes mellitus risk using non-linear heart rate variability features
R. Shashikant, Uttam M. Chaskar, Leena Phadke, C. Y. Patil · 2021 · Biomedical Engineering Letters
Cardiometabolic-based chronic disease: adiposity and dysglycemia drivers of heart failure
Eduardo Thadeu de Oliveira Correia, Jeffrey Ian Mechanick, Letícia Mara dos Santos Barbetta, Antônio José Lagoeiro Jorge, Evandro Tinoco Mesquita · 2022 · Heart Failure Reviews
Vascular complications in prediabetes and type 2 diabetes: a continuous process arising from a common pathology
Ulrike Gottwald‐Hostalek, Mike Gwilt · 2022 · Current Medical Research and Opinion
Plasma fingerprint of free fatty acids and their correlations with the traditional cardiac biomarkers in patients with type 2 diabetes complicated by coronary heart disease
Ting Hu, Wen Zhang, Feifei Han, Rui Zhao, Lihong Liu, Zhuoling An · 2022 · Frontiers in Cardiovascular Medicine
The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure
Alexander A. Berezin, Zeljko Obradovic, Ivan M. Fushtey, Tetiana A. Berezina, Evgen V. Novikov, Lukas Schmidbauer, Michael Lichtenauer, Alexander Е. Berezin · 2023 · Biomedicines
Leveraging calcium score CT radiomics for heart failure risk prediction
Singh, Prerna, Hoori, Ammar, Freeze, Joshua, Hu, Tao, Tashtish, Nour, Gilkeson, Robert, Li, Shuo, Rajagopalan, Sanjay, Wilson, David L., Al-Kindi, Sadeer · 2024 · Scientific Reports
Management of heart failure and type 2 diabetes mellitus: Maximizing complementary drug therapy
Javed Butler, James L. Januzzi, Julio Rosenstock · 2020 · Diabetes Obesity and Metabolism
Chronic heart failure and type 2 diabetes: state of the problem
Andrey E. Bagriy, Evgeniy V. Suprun, E. S. Mykhailichenko, I.A. Golodnikov Golodnikov · 2020 · Russian Journal of Cardiology
Incidence of adverse cardiovascular events in type 2 diabetes mellitus patients after initiation of glucose‐lowering agents: A population‐based community study from the Shizuoka Kokuho database
Shun Kohsaka, Hiraku Kumamaru, Shiori Nishimura, Satoshi Shoji, Eiji Nakatani, Nao Ichihara, Hiroyuki Yamamoto, Yoshiki Miyachi, Hiroaki Miyata · 2020 · Journal of Diabetes Investigation
Impact of multimorbidity patterns on outcomes and treatment in patients with coronary artery disease
Wen Zheng, Xin Huang, Wang Xiao, Min Suo, Yan Yan, Wei Gong, Hui Ai, Bin Que, Shaoping Nie · 2024 · European Heart Journal Open
Glimepiride use is associated with reduced cardiovascular mortality in patients with type 2 diabetes and chronic heart failure: a prospective cohort study
Wu He, Gang Yuan, Yu Han, Yongcui Yan, Gen Li, Chengcheng Zhao, Jingshan Shen, Xiangrui Jiang, Chen Chen, Li Ni et al. · 2022 · European Journal of Preventive Cardiology
Prospective associations between diet quality, dietary components, and risk of cardiometabolic multimorbidity in older British men
Qiaoye J. Wang, Amand Floriaan Schmidt, LUCY T. LENNON, Olia Papacosta, Peter Hynes Whincup, S. Goya Wannamethee · 2023 · European Journal of Nutrition
Chinese herbal medicine and active ingredients for diabetic cardiomyopathy: molecular mechanisms regulating endoplasmic reticulum stress
Lianjun Ao, Zhengtao Chen, Jiacheng Yin, Yulin Leng, Yue Luo, Xiaoxu Fu, Hanyu Liu, Xiaoke Liu, Hong Gao, Chunguang Xie · 2023 · Frontiers in Pharmacology
Effect of SGLT-2 inhibitor, dapagliflozin, on left ventricular remodeling in patients with type 2 diabetes and HFrEF
Qianyu Fu, Longhua Zhou, Yuqin Fan, Fenfen Liu, Yuanyuan Fan, Xin Zhang, Wang Li, Lan Cheng · 2023 · BMC Cardiovascular Disorders
Multifaceted remodelling of cAMP microdomains driven by different aetiologies of heart failure
Kirstie A. De Jong, Viacheslav O. Nikolaev · 2021 · FEBS Journal
Comprehensive Multiple Risk Factor Control in Type 2 Diabetes to Mitigate Heart Failure Risk: Insights From a Prospective Cohort Study
Ze-Gui Huang, Jing‐Wei Gao, Zhi-Teng Chen, Haifeng Zhang, Si You, Zhuo-Chao Xiong, Yu‐Biao Wu, Qing‐Yuan Gao, Jingfeng Wang, Yangxin Chen et al. · 2024 · Diabetes Care
The immunology of diabetic cardiomyopathy
Ming Song, Honggang Dai, Quan Zhou, Xiao Meng · 2025 · Frontiers in Endocrinology
The continuum of prevention and heart failure in cardiovascular medicine: A joint scientific statement from the Heart Failure Society of America and the American Society for Preventive Cardiology
Anuradha Lala, Craig James Beavers, Vanessa L. Blumer, LaPrincess C. Brewer, Diana De Oliveira-Gomes, Sandra Barker Dunbar, Hannah Every, Richard Ferraro, Bonnie Ky, James L. Januzzi et al. · 2025 · American Journal of Preventive Cardiology
The majority of type 2 diabetic patients in Finnish primary care are at very high risk of cardiovascular events: A cross-sectional chart review study (STONE HF)
Kaj Peter Metsarinne, Mikko Pietilä, Ilkka M Kantola, Lotta K. Stenman, Olli-Pekka Hätinen, Aino Vesikansa, Tuija Annika Poussa, LEO K. NISKANEN · 2021 · Primary care diabetes
Effect of Sodium-Glucose Cotransporter Inhibitors on Major Adverse Cardiovascular Events and Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus and Atrial Fibrillation
Chang Hee Kwon, Ye‐Jee Kim, Min-Ju Kim, Myung‐Jin Cha, Min Soo Cho, Gi‐Byoung Nam, Kee‐Joon Choi, Jun Kim · 2022 · The American Journal of Cardiology
The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure
Alexander A. Berezin, Ivan M. Fushtey, Alexander Е. Berezin · 2022 · Biomedicines
Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets
Misganaw Asmamaw Mengstie, Endeshaw Chekol Abebe, Awgichew Behaile Teklemariam, Anemut Tilahun Mulu, Assefa Agegnehu Teshome, Edgeit Abebe Zewde, Zelalem Tilahun Muche, Muluken Teshome Azezew · 2022 · Frontiers in Endocrinology
Chronic kidney disease begets heart failure and vice versa: temporal associations between heart failure events in relation to incident chronic kidney disease in type 2 diabetes
Mei‐Zhen Wu, Tiew‐Hwa Katherine Teng, Wan-Ting Tay, Q W Ren, Jasper Tromp, Wouter Ouwerkerk, Chanchal Chandramouli, Jiayi Huang, Yap‐Hang Chan, KANAKO TERAMOTO et al. · 2022 · Diabetes Obesity and Metabolism
Canagliflozin inhibits inflammasome activation in diabetic endothelial cells – Revealing a novel calcium-dependent anti-inflammatory effect of canagliflozin on human diabetic endothelial cells
Xiaoling Li, Raphaela P. Kerindongo, Benedikt Preckel, Jan-Ole Kalina, Markus Werner Hollmann, Coert Jozef Zuurbier, Nina Claudia Weber · 2023 · Biomedicine & Pharmacotherapy
Mortality and Morbidity in HFrEF, HFmrEF, and HFpEF Patients with Diabetes in the Middle East
Mohammed Al‐Jarallah, Rajesh Rajan, Ibrahim S Al-Zakwani, Raja Dashti, Bassam Bulbanat, Mustafa Ridha, Kadhim Sulaiman, Alawi A.A. Alsheikh-Ali, Prashanth Panduranga, Khalid F. AlHabib et al. · 2020 · Oman Medical Journal
Type 2 Diabetes and Heart Failure: Insights from the Global DISCOVER Study
Suzanne V. Arnold, Kamlesh K. Khunti, Fabrice Bonnet, Bernard H. Charbonnel, Hungta Chen, Javier Cid‐Ruzafa, Andrew Cooper, Peter Fenici, Marília Brito Gomes, Niklas Hammar et al. · 2021 · ESC Heart Failure
Heart Failure in Type 1 Diabetes: A Complication of Concern? A Narrative Review
Ana María Gómez‐Pérez, Miguel Damas-Fuentes, Isabel María Cornejo-Pareja, Francisco José Tinahones · 2021 · Journal of Clinical Medicine
Artificial Intelligence to Diagnose Complications of Diabetes
Alessandra T. Ayers, Cindy Ho, David E. Kerr, Simon Lebech Cichosz, Nestoras Nicolas Mathioudakis, Michelle Wang, Bijan Najafi, Sun Joon Moon, Ambarish Pandey, David Charles Klonoff · 2024 · Journal of Diabetes Science and Technology
Association between single-point insulin sensitivity estimator and heart failure in older adults: A cross-sectional study
Xiaofeng Zhu, Ye-Tong Mo, Yuqi Hu, Yu-Xue Feng, En-Hui Liu · 2024 · Experimental Gerontology
Bridging the Gap for Patients with Diabetes and Cardiovascular Disease Through Cardiometabolic Collaboration
Lee‐Shing Chang, Muthiah Vaduganathan, Jorge Plutzky, Vanita R. Aroda · 2019 · Current Diabetes Reports
Incidence and Management of Carfilzomib-induced Cardiovascular Toxicity; A Systematic Review and Meta-analysis
Azka Latif, Vikas Kapoor, Noman Lateef, Muhammad Junaid Ahsan, Rana M. Usman, Saad Ullah Malik, Naqib Ahmad, Nathaniel Rosko, Joslyn Rudoni, Preethi William et al. · 2021 · Cardiovascular & Haematological Disorders - Drug Targets
Insulin treatment in patients with diabetes mellitus and heart failure in the era of new antidiabetic medications
L. Staszewsky, M. Baviera, M. Tettamanti, P. Colacioppo, F. Robusto, A. D'Ettorre, V. Lepore, I. Fortino, L. Bisceglia, E. Attolini et al. · 2022 · BMJ Open Diabetes Research & Care
Heart failure and diabetes: Clinical significance and epidemiology of this two‐way association
Terri W. Jerkins, Janet B. McGill, David S.H. Bell · 2023 · Diabetes Obesity and Metabolism
Significance of Endothelial Dysfunction Amelioration for Sodium–Glucose Cotransporter 2 Inhibitor-Induced Improvements in Heart Failure and Chronic Kidney Disease in Diabetic Patients
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, Hisayuki Katsuyama · 2023 · Metabolites
Metformin: Expanding the Scope of Application—Starting Earlier than Yesterday, Canceling Later
Yulia A. Kononova, Nikolai P. Likhonosov, Alina Yu. Babenko · 2022 · International Journal of Molecular Sciences
Study of long non-coding RNA and mitochondrial dysfunction in diabetic rats
Haytham K. Sultan, Wael M. Elayat, Azza Hassan AbouGhalia, Noha N. Lasheen, Amr Soliman Moustafa · 2021 · Tissue and Cell
Changes in Myocardial Metabolism Preceding Sudden Cardiac Death
Jonathan E. Snyder, Ruxu Zhai, Atreju I. Lackey, Priscila Y. Sato · 2020 · Frontiers in Physiology
Eligibility of Outpatients with Chronic Heart Failure for Sodium–Glucose Co-Transporter-2 Inhibitors
Gianmarco Angelini, Miriam Albanese, Raffaella Ursi, Francesco Lisi, Maria Consiglia Bellino, Luca Amato, Margherita Ilaria Gioia, Giuseppe Parisi, Natale Daniele Brunetti, Giuseppina Piazzolla et al. · 2021 · ESC Heart Failure
Impact of insulin therapy on outcomes of diabetic patients with heart failure: A systematic review and meta-analysis
Jingxing Liu, Xinhua Hu · 2022 · Diabetes and Vascular Disease Research
Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction
Brahim Redouane, Stephen John Greene, Marat Fudim, Muthiah Vaduganathan, Andrew P. Ambrosy, Jie‐Lena Sun, Adam D. DeVore, Steven E. McNulty, Robert John Mentz, Adrian F. Hernandez et al. · 2020 · Circulation Heart Failure
Diabetes With Cardiomyopathy
Vanita R. Aroda, Pam R. Taub, Ana Maria Stanton · 2021 · Journal of the American College of Cardiology
Associations of glycosylated hemoglobin, pre-diabetes, and type 2 diabetes with incident lung cancer: A large prospective cohort study
Junjie Hua, Huan Lin, Xiaojie Wang, Zhengmin Qian, Michael G. Vaughn, Maya Tabet, Chongjian Wang, Hualiang Lin · 2024 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
The prevalence of cardiovascular diseases, chronic kidney disease, and obesity in patients with type 2 diabetes mellitus and the description of concurrent treatments: A two-center retrospective cross-sectional study in Saudi Arabia
Omar A. Alshaya, Ghazwa B. Korayem, Munirah Alghwainm, Wed Alyami, Albandari Alotaibi, Majed S. Al Yami, Omar A. Almohammed · 2024 · Saudi Pharmaceutical Journal
Heart Failure in Elderly Patients: Medical Management, Therapies and Biomarkers
Paulina Nadziakiewicz, Wioletta Szczurek, Bożena Szyguła‐Jurkiewicz · 2024 · Pharmaceuticals
Linagliptin prevents left ventricular stiffening by reducing titin cleavage and hypophosphorylation
Ilona Cuijpers, Anna‐Pia Papageorgiou, Paolo Carai, Melissa Herwig, Andreas Mügge, Thomas Klein, Nazha Hamdani, Elizabeth A. V. Jones, Stephane R B Heymans · 2020 · Journal of Cellular and Molecular Medicine
Circadian disruption by short light exposure and a high energy diet impairs glucose tolerance and increases cardiac fibrosis in Psammomys obesus
Victoria A. Nankivell, Joanne T. M. Tan, Laura A. Wilsdon, Kaitlin R. Morrison, Carmel Bilu, Peter James Psaltis, Paul Zimmet, Noga Kronfeld‐Schor, Stephen James Nicholls, Christina A. Bursill et al. · 2021 · Scientific Reports
Physical Rehabilitation in Older Patients Hospitalized with Acute Heart Failure and Diabetes: Insights from REHAB-HF
Evan M. Murray, David J. Whellan, Haiying Chen, Alain Gerald Bertoni, Pamela Woods Duncan, Amy M. Pastva, Dalane W. Kitzman, Robert John Mentz · 2021 · The American Journal of Medicine
Impact of diabetes mellitus on outcome after transcatheter aortic valve replacement: Identifying high‐risk diabetic population from the OCEAN‐TAVI registry
Shingo Matsumoto, Yohei Ohno, Junichi Miyamoto, Yuji Ikari, Norio Tada, Toru Naganuma, Masahiro Yamawaki, Futoshi Yamanaka, Shinichi Shirai, Kazuki Mizutani et al. · 2021 · Catheterization and Cardiovascular Interventions
County-level variation in cardioprotective antihyperglycemic prescribing among medicare beneficiaries
Jonathan M. Hanna, Arash Aghajani Nargesi, Utibe R. Essien, Veer Sangha, Zhenqiu Lin, Harlan M. Krumholz, Rohan Khera · 2022 · American Journal of Preventive Cardiology
Reasons for hospitalisation in Australians with type 2 diabetes compared to the general population, 2010–2017
Dunya Tomic, Agus Salim, Jedidiah I Morton, Dianna J. Magliano, Jonathan E. Shaw · 2022 · Diabetes Research and Clinical Practice
Incidence, Clinical Correlates, and Prognostic Impact of Dementia in Heart Failure
Q W Ren, Tiew‐Hwa Katherine Teng, Yi-Kei Tse, Wan Ting Tay, Hang‐Long Li, Jasper Tromp, Si-Yeung Yu, Denise Hung, Mei‐Zhen Wu, Christopher Chen et al. · 2023 · JACC Asia
NT-proBNP point-of-care measurement as a screening tool for heart failure and CVD risk in type 2 diabetes with hypertension
Antonio Ceriello, Nebojsa M. Lalic, Eduard Montanya, Paul Elie Valensi, Kamlesh K. Khunti, Michael Hummel, Oliver Schnell · 2023 · Journal of Diabetes and its Complications
Can HDL cholesterol be replaced by paraoxonase 1 activity in the prediction of severe coronary artery disease in patients with type 2 diabetes?
Abdolkarim Mahrooz, Omeh Farveh Khosravi-Asrami, Ahad Alizadeh, Neda Mohmmadi, Abouzar Bagheri, Zahra Kashi, Adele Bahar, Mani Nosrati, Mike Mackness · 2023 · Nutrition Metabolism and Cardiovascular Diseases
Association Between Elevated Total Homocysteine and Heart Failure Risk in the Multi‐Ethnic Study of Atherosclerosis Cohort
Amy B. Karger, Sarah J. O. Nomura, Weihua Guan, Parveen K. Garg, Geoffrey H. Tison, Moysés Szklo, Matthew Jay Budoff, Michael Y. Tsai · 2025 · Journal of the American Heart Association
Prediction models of diabetes complications: a scoping review
Ruth Ndjaboué, Gérard Ngueta, Charlotte Rochefort-Brihay, Sasha Delorme, Daniel Guay, Noah Michael Ivers, Baiju R. Shah, Sharon Elizabeth Straus, Catherine H. Y. Yu, Sandrine Comeau et al. · 2022 · Journal of Epidemiology & Community Health
Assessment of Atherothrombotic Risk in Patients With Type 2 Diabetes Mellitus
David D. Berg, Filipe A. Moura, Andrea Bellavia, Benjamin M. Scirica, Stephen D. Wiviott, Deepak L. Bhatt, Itamar Raz, Erin Ann Bohula, Robert Patrick Giugliano, Jeong‐Gun Park et al. · 2023 · Journal of the American College of Cardiology
GPER activation attenuates cardiac dysfunction by upregulating the SIRT1/3-AMPK-UCP2 pathway in postmenopausal diabetic rats
Hossein Azizian, Zeinab Farhadi, Michael Bäder, Jalil Alizadeh Ghalenoei, Mohammad Amin Ghafari, Shokoufeh Mahmoodzadeh · 2023 · PLoS ONE
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects
M. Riemma, E. Mele, M. Donniacuo, M. Telesca, G. Bellocchio, G. Castaldo, Francesco Rossi, A. De Angelis, D. Cappetta, K. Urbanek et al. · 2024 · Frontiers in Pharmacology
U shape association between triglyceride glucose index and congestive heart failure in patients with diabetes and prediabetes
Yumeng Shi, Chao Yu · 2024 · Nutrition & Metabolism
Impact of hypoglycemia at the time of hospitalization for heart failure from emergency department on major adverse cardiovascular events in patients with and without type 2 diabetes
Seon‐Ah Cha, Jae‐Seung Yun, Gee-Hee Kim, Yu‐Bae Ahn · 2022 · Cardiovascular Diabetology
Evaluation and Management of Patients with Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement
Kyu‐Sun Lee, Jung Hyun Noh, Seong‐Mi Park, Kyung Mook Choi, Seok‐Min Kang, Kyu Chang Won, Hyun‐Jai Cho, Min Kyong Moon, Korean Society of Heart Failure · 2023 · Diabetes & Metabolism Journal
Type 2 Diabetes Mellitus: A Metabolic Model of Accelerated Aging - Multi-Organ Mechanisms and Intervention Approaches
Ziran Zhang, Xiaolin He, Yuxin Sun, Jitong Li, Jia Sun · 2025 · Aging and Disease
Current Perspectives on GLP-1 Agonists in Contemporary Clinical Practice from Science and Mechanistic Foundations To Optimal Translation
Husam Abu-Nejim, Richard Clinton Becker · 2025 · Current Atherosclerosis Reports
Is non-alcoholic fatty liver disease a sign of left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus? A systematic review and meta-analysis
Sicheng Wang, Xiangyuan Zhang, Qiqi Zhang, Boxun Zhang, Linhua Zhao · 2023 · BMJ Open Diabetes Research & Care
An Overview of Diabetic Cardiomyopathy
Abdul Quaiyoom, Ranjeet Kumar · 2023 · Current Diabetes Reviews
Patient Awareness of Heart Failure Diagnosis: A Community Study
Stacie J. Shropshire, Matteo Fabbri, Sheila M. Manemann, Veronique Lee Roger, Jill M. Killian, Susan A. Weston, Alanna M. Chamberlain · 2023 · Journal of the American Heart Association
Ethnic Disparities in the Risk Factors, Morbidity, and Mortality of Cardiovascular Disease in People With Diabetes
Lekshmi Nair, Peace Asuzu, Samuel E. Dagogo-Jack · 2024 · Journal of the Endocrine Society
The Role of Natriuretic Peptides in the Management of Heart Failure with a Focus on the Patient with Diabetes
Michela Vergani, Rosa Cannistraci, Gianluca Perseghin, Stefano Ciardullo · 2024 · Journal of Clinical Medicine
Association of triglyceride-glucose index trajectories with the risk of worsening heart failure in elderly patients with chronic heart failure and type 2 diabetes: a competing risk analysis
Yingying Lai, Cailong Lin, Xin-Dong Liu, Yu-Ting Liu, Hua Cai, Nan-Nan Zhao, Yu-Shuo Gao, Zi-Yi Yi, Jian-Yu Huang, Min Li et al. · 2025 · Cardiovascular Diabetology
Comparison of clinical outcomes and left ventricular remodeling after ST-elevation myocardial infarction between patients with and without diabetes mellitus
Naoyuki Akashi, Takunori Tsukui, Kei Yamamoto, Masaru Seguchi, Yousuke Taniguchi, Kenichi Sakakura, Hiroshi Wada, Shin‐ichi Momomura, Hideo Fujita · 2021 · Heart and Vessels
The Effects of Dapagliflozin in Patients With Heart Failure Complicated With Type 2 Diabetes: A Meta-Analysis of Placebo-Controlled Randomized Trials
Miaobo Zhai, Xin Du, Liu Changmei, Huipu Xu · 2021 · Frontiers in Clinical Diabetes and Healthcare
Brain Imaging Changes and Related Risk Factors of Cognitive Impairment in Patients With Heart Failure
Yangyang Jiang, Lei Wang, Ziwen Lu, Shiqi Chen, Yu Teng, Tong Li, Yang Li, Yingzhen Xie, Mingjing Zhao · 2022 · Frontiers in Cardiovascular Medicine
Effects of sacubitril/valsartan on both metabolic parameters and insulin resistance in prediabetic non-obese patients with heart failure and reduced ejection fraction
Cosima Cloro, Isabella Zaffina, Luca Sacchetta, Federico Arturi, Cristina Clausi, Stefania Lucà, Maria Chiara Pelle, Federica Giofrè, Giuseppe Armentaro, Valentina Forte et al. · 2022 · Frontiers in Endocrinology
Advances in contemporary medical management to treat patients with heart failure
Mauricio Velez · 2023 · Current Opinion in Cardiology
Exercise and Urtica Dioica extract ameliorate mitochondrial function and the expression of cardiac muscle Nuclear Respiratory Factor 2 and Peroxisome proliferator-activated receptor Gamma Coactivator 1-alpha in STZ-induced diabetic rats
Seyyedeh Masoumeh Seyyedi, Asghar Tofighi, Masoud Rahmati, Javad Tolouei ‌Azar · 2022 · Gene
Risk trajectories of complications in over one thousand newly diagnosed individuals with type 2 diabetes
Gudrún Höskuldsdóttir, Stefan Franzén, Katarina Eeg‐Olofsson, Björn Eliasson · 2022 · Scientific Reports
Protective effect of intermediate doses of hydrogen sulfide against myocardial ischemia-reperfusion injury in obese type 2 diabetic rats
Sajad Jeddi, Sevda Gheibi, Khosrow Kashfi, Mattias Carlström, Asghar Ghasemi · 2020 · Life Sciences
Management of Heart Failure With Preserved Ejection Fraction: 2026 ACC Expert Consensus Decision Pathway
M D Kittleson, Gurusher Singh Panjrath, Katie Bates, Khadijah K Breathett, Dave L. Dixon, James L. Januzzi, Selma F. Mohammed · 2026 · Journal of the American College of Cardiology
Derivation and External Validation of a Clinical Model to Predict Heart Failure Onset in Patients With Incident Diabetes
Louise Y. Sun, Salwa S. Zghebi, Anan Bader Eddeen, Peter P. Liu, Douglas S. Lee, Karen Tu, Sheldon W. Tobe, Evangelos Kontopantelis, Mamas A. Mamas · 2022 · Diabetes Care